PHCY5630 Integrated Pharmacology, Therapeutics and Pharmacy Practice 3

Credit
6 points
Offering
(see Timetable)
AvailabilityLocationMode
Non-standard teaching periodUWA (Perth)Face to face
Content
This unit continues to provide detailed pharmacology and pharmacotherapy of major disease states and further expands on the pharmacokinetics and pharmacodynamics of drugs first introduced to students in PHCY5602 Pharmacy Practice and Pharmacotherapy 1. An emphasis is placed on the student increasing their awareness of the patient as a whole through the concept of patient centred care.

Pharmacology and pharmacotherapy is presented in an integrated fashion and will provide an in-depth look at the pharmacists' role in the management of major disease states. Special emphasis is placed on the development of therapeutic management plans, that include monitoring for efficacy and safety of treatment regimens. A case-based approach to learning will ensure that the student focus is on the key learning objectives. The cases are selected so that they challenge the students' understanding of the topic and provide ground for discussion between the student and the topic tutor.

Other topics include therapeutic drug monitoring; drug interactions; sources of inter-patient variability in pharmacokinetics, clinical case studies and pharmacokinetics of specific drugs. The extensive use of clinically-oriented problems and cases during case-based workshop will enable students to apply these principles to real-world examples in preparation for hospital placements.
Outcomes
Students are able to (1) describe the mechanism of action, pharmacological effects, pharmacokinetic properties, therapeutic uses, contraindications, adverse effects and clinically significant drug interactions of the principal drugs and drug classes used to treat various conditions; (2) apply knowledge of pharmacological principles and major disease states to clinical decision-making; (3) understand and explain pharmacokinetic principles and the principles of absorption, distribution, metabolism and elimination; (4) understand how interference with absorption, distribution, metabolism and elimination can lead to clinically important drug interactions and be able to predict potential drug interactions from a working knowledge of their metabolic pathway.; (5) apply the principles of pharmacokinetics and pharmacodynamics in special populations including children, geriatrics, pregnancy, lactation, pharmacogenetics, renal and hepatic disease; (6) apply pharmacokinetic parameters to correctly interpret drug concentrations and to calculate dosage regimens for drugs requiring therapeutic drug monitoring in different populations.; (7) understand the key concepts of toxicology; and (8) interpret common laboratory test results and apply these to clinical scenarios.
Assessment
Indicative assessments in this unit are as follows: (1) ongoing assessments; (2) oral assessment; and (3) written examination. Further information is available in the unit outline.

To pass this unit, a student must: (a) achieve an overall mark of 50 per cent or higher for the unit; and (b) achieve the requisite requirements(s) or a mark of 50 per cent or greater, whichever is higher and specified in the unit outline, for the oral assessment component.

A supplementary assessment may be offered if a student achieves a final mark of 45 - 49% in PHCY5612 or PHCY5630 but not both.
Unit Coordinator(s)
Dr Sandra Salter
Unit rules
Prerequisites:
enrolment in the Master of Pharmacy; PHCY5615 Pharmacy Placement I
Co-requisites:
PHCY5612 Integrated Pharmacology, Therapeutics and Pharmacy Practice 2
Contact hours
Lectures and workshop: 4 hours per week; tutorials: 2 hours per week
Unit Outline
Non-standard teaching period [TS-K-1_2019]
Texts

Required texts
1. Australian Pharmaceutical Formulary and Handbook. Current edition. PSA.
2. Australian Medicines Handbook. Current edition. PSA.

Recommended texts
Chen, T et al. Case Studies in Practice - Medication Review: A Process Guide for Pharmacists. Current edition. PSA.

Chen, T et al. Case Studies in Practice. Pharmacist only and pharmacy medicines: a process guide for pharmacists. Current edition. PSA.

DiPiro J et al. Concepts in Clinical Pharmacokinetics. Current edition. American Society if Health-System Pharmacy.

Gowan J and Roller L. Practical disease state management for pharmacists. Current edition. APPCo.

Hughes, J. Case Studies in Practice. Use of Laboratory Test Data. Current edition. PSA.

Kumar V, Abbas AK, Fausto N, AsterJ.  Robbins and Cotran Pathologic basis of disease. Current edition. Elsevier Health Sciences‎

Rang, H et al. Rang and Dale’s Pharmacology. Current edition. Elsevier

Tozer et al. Essentials of Pharmacokinetics and Pharmacodynamics. Current edition. Lippincott, Williams & Wilkins

Walker, R and Edwards, C. Clinical Pharmacy and Therapeutics. Churchill Livingstone. Current edition.

  • The availability of units in Semester 1, 2, etc. was correct at the time of publication but may be subject to change.
  • All students are responsible for identifying when they need assistance to improve their academic learning, research, English language and numeracy skills; seeking out the services and resources available to help them; and applying what they learn. Students are encouraged to register for free online support through GETSmart; to help themselves to the extensive range of resources on UWA's STUDYSmarter website; and to participate in WRITESmart and (ma+hs)Smart drop-ins and workshops.
  • Books and other material wherever listed may be subject to change. Book lists relating to 'Preliminary reading', 'Recommended reading' and 'Textbooks' are, in most cases, available at the University Co-operative Bookshop (from early January) and appropriate administrative offices for students to consult. Where texts are listed in the unit description above, an asterisk (*) indicates that the book is available in paperback.